CT beats fluoroscopy for Crohn's disease anomalies
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
The big advantage of CT enteroclysis is its ability to detect complications that exist outside normal parameters of the diagnosis and identification of Crohn's disease, according to principal investigator Dr. Johannes Sailer, a radiologist at the Medical University of Vienna.
Researchers evaluated with both techniques 50 symptomatic patients. Results were matched with surgery and follow-up (AJR 2005;185;1575-1581). CT enteroclysis proved better than conventional enteroclysis at detecting fistulae, abscesses, and conglomeration of small bowel loops. CT enteroclysis also proved equivalent to standard imaging in the detection of minimal mucosal changes.
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
